Literature DB >> 11306466

Tumor vascularity: a histological measure of angiogenesis and hypoxia.

C M West1, R A Cooper, J A Loncaster, D P Wilks, M Bromley.   

Abstract

In this study we sought to clarify the relationship between tumor vascularity, hypoxia, and angiogenesis in human cervix tumors. Two hypotheses were established: first, that measurement of tumor vascularity can provide a histological assessment of both hypoxia and angiogenesis; and second, that expression of angiogenesis-related proteins will provide a surrogate measure of tumor hypoxia. To test the first hypothesis, we studied the prognostic significance of tumor vascularity measured as both intercapillary distance (ICD; thought to reflect tumor oxygenation) and microvessel density (MVD; the hotspot method that provides a histological assessment of tumor angiogenesis). The relationship was also examined of tumor hypoxia, measured using an Eppendorf needle electrode [percentage of values less than 5 mm Hg (HP5)], with ICD and MVD. To test the second hypothesis we examined the relationship between HP5 and the expression of angiogenesis-associated proteins [vascular endothelial growth factor (VEGF) and platelet-derived endothelial cell growth factor (PD-ECGF)]. All of the biological measurements were made on pretreatment tumors. Analysis of data was carried out using log-rank statistics, Cox multivariate analysis, and Spearman's rank correlation. Both ICD and MVD were significant independent prognostic factors for local control. Patients with poorly vascularized tumors (long ICD) had poor local control (P = 0.042). However, patients with poorly vascularized tumors, measured as low MVD, had good local control (P = 0.036). For 107 patients in whom both of the measurements were obtained on the same tumor sections, ICD and MVD provided independent prognostic information in multivariate analysis. There was a significant correlation between tumor hypoxia and ICD (P < 0.005) but not MVD (P = 0.41). There was no relationship between hypoxia and the expression of angiogenic factors (VEGF, PD-ECGF). These analyses show that measurement of tumor vascularity can provide different biological information that is dependent on the method used. It is, therefore, important that studies measuring vascularity should include an appropriate definition. There is no relationship between hypoxia and angiogenesis in advanced carcinoma of the cervix and examining the levels of angiogenic proteins may not have a role in assessing hypoxia in cervix cancer.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11306466

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  22 in total

1.  Modulatory effect of high saturated fat diet-induced metabolic disturbances on angiogenic response in hepatocyte RXRα knockout mice.

Authors:  Urszula Raźny; Łukasz Wątor; Anna Polus; Beata Kieć-Wilk; Yu-Jui Yvonne Wan; Grzegorz Dyduch; Romana Tomaszewska; Aldona Dembińska-Kieć
Journal:  Pharmacol Rep       Date:  2010 Nov-Dec       Impact factor: 3.024

Review 2.  Current research directions for locally advanced cervix cancer.

Authors:  Harry J Long
Journal:  Curr Oncol Rep       Date:  2003-11       Impact factor: 5.075

3.  Response of HT29 colorectal xenograft model to cediranib assessed with 18 F-fluoromisonidazole positron emission tomography, dynamic contrast-enhanced and diffusion-weighted MRI.

Authors:  Louisa Bokacheva; Khushali Kotedia; Megan Reese; Sally-Ann Ricketts; Jane Halliday; Carl H Le; Jason A Koutcher; Sean Carlin
Journal:  NMR Biomed       Date:  2012-07-08       Impact factor: 4.044

Review 4.  Predicting outcomes in radiation oncology--multifactorial decision support systems.

Authors:  Philippe Lambin; Ruud G P M van Stiphout; Maud H W Starmans; Emmanuel Rios-Velazquez; Georgi Nalbantov; Hugo J W L Aerts; Erik Roelofs; Wouter van Elmpt; Paul C Boutros; Pierluigi Granone; Vincenzo Valentini; Adrian C Begg; Dirk De Ruysscher; Andre Dekker
Journal:  Nat Rev Clin Oncol       Date:  2012-11-20       Impact factor: 66.675

5.  Esophageal squamous cell carcinoma: assessing tumor angiogenesis using multi-slice CT perfusion imaging.

Authors:  Tao Song; Yu-Guang Shen; Na-Na Jiao; Xin-Hui Li; Hong-Tao Hu; Jin-Rong Qu; Xue-Jun Chen; Wen Feng; Xun Zhang; Hai-Liang Li
Journal:  Dig Dis Sci       Date:  2012-04-03       Impact factor: 3.199

6.  Angiogenesis in Balb/c mice under beta-carotene supplementation in diet.

Authors:  Urszula Razny; Anna Polus; Beata Kiec-Wilk; Lukasz Wator; Jadwiga Hartwich; Jerzy Stachura; Romana Tomaszewska; Grzegorz Dyduch; Piotr Laidler; Gerd Schmitz; Regina Goralczyk; Karin Wertz; George Riss; Nicole L W Franssen-van Hal; Jaap Keijer; Aldona Dembinska-Kiec
Journal:  Genes Nutr       Date:  2009-11-28       Impact factor: 5.523

7.  Expansion of endothelial surface by an increase of vessel diameter during tumor angiogenesis in experimental and hepatocellular and pancreatic cancer.

Authors:  Eduard Ryschich; Eduard Schmidt; Sasa-Marcel Maksan; Ernst Klar; Jan Schmidt
Journal:  World J Gastroenterol       Date:  2004-11-01       Impact factor: 5.742

8.  A preclinical model for noninvasive imaging of hypoxia-induced gene expression; comparison with an exogenous marker of tumor hypoxia.

Authors:  Bixiu Wen; Paul Burgman; Pat Zanzonico; Joseph O'donoghue; Shangde Cai; Ron Finn; Inna Serganova; Ronald Blasberg; Juri Gelovani; Gloria C Li; C Clifton Ling
Journal:  Eur J Nucl Med Mol Imaging       Date:  2004-09-16       Impact factor: 9.236

9.  Hepatocyte RXR alpha deletion in mice leads to inhibition of angiogenesis.

Authors:  Urszula Razny; Lukasz Wator; Anna Polus; Yu-Jui Yvonne Wan; Grzegorz Dyduch; Romana Tomaszewska; Aldona Dembinska-Kiec
Journal:  Genes Nutr       Date:  2009-02-18       Impact factor: 5.523

Review 10.  The tumor microenvironment and metastatic disease.

Authors:  Sarah Jane Lunt; Naz Chaudary; Richard P Hill
Journal:  Clin Exp Metastasis       Date:  2008-06-10       Impact factor: 5.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.